Bruce Booth

Bruce Booth is a seasoned venture capital partner at Atlas Venture, specializing in early-stage investments within the life sciences sector since October 2005. Active in various leadership roles, Bruce currently serves as Chairman of the Board for multiple biotechnology companies, including Kymera Therapeutics, Nimbus Therapeutics, Vigil Neuroscience, Arkuda Therapeutics, HotSpot Therapeutics, and AVROBIO. Additionally, Bruce holds Board Director positions at Sionna Therapeutics and Matchpoint Therapeutics, having previously directed efforts at Magenta Therapeutics until June 2023. Academic credentials include a D.Phil. in Immunology from the University of Oxford and a B.S. in Biochemistry from Penn State University.